Pfizer plans to file for emergency-use authorisation from the FDA
– Vaccine shown to be 95% effective in final efficacy analysis of Phase 3 trial
– Plans to file for emergency-use authorisation within days
Risk trades are getting another shot in the arm on the news here, albeit a more modest one this time around. European stocks are
– Vaccine shown to be 95% effective in final efficacy analysis of Phase 3 trial
– Plans to file for emergency-use authorisation within days
Risk trades are getting another shot in the arm on the news here, albeit a more modest one this time around. European stocks are